Transforming growth factor beta1 (TGF-ß1) levels in a rat model of induced pleural empyema

Acta Cir Bras. 2018 Feb;33(2):156-162. doi: 10.1590/s0102-865020180020000007.

Abstract

Purpose: To evaluate the concentration of transforming growth factor beta 1 (TGFB1) levels in a rat pleural effusion obtained by inoculation of intrapleural bacteria or turpentine through thoracentesis.

Methods: Thirty-Nine Wistar rats were divided into three groups: Staphylococcus aureus (SA, n = 17); Streptococcus pneumoniae (SP, n = 12); and turpentine (control, n = 10). Pleural fluid was collected through ultrasound-guided thoracentesis 12 h, 24 h, and 36 h after instillation of bacteria or turpentine. Levels of TGFB1 were measured in pleural fluid.

Results: At 12 h, mean TGFB1concentrations were 5.3450 pg/mL in the SA group, 5.3449 pg/mL in the SP group, and 5.3450 pg/mL in controls. At 24 h, they were 4.6700 pg/mL in the SA group, 4.6700 pg/mL in the SP group, and 4.6700 pg/mL in controls. At 36 h, they were 4.6699 pg/mL in the SA group and in control. No difference was observed among the groups in mean TGFB1concentration (p = 0.12); however, a significant intragroup reduction in mean TGFB1 was observed between 12 and 24 h (p < 0.01).

Conclusion: The transforming growth factor beta 1 concentrations were not useful as a diagnostic tool or an early marker of infected pleural effusion.

MeSH terms

  • Animals
  • Bacteria / pathogenicity
  • Biomarkers / analysis
  • Disease Models, Animal
  • Empyema, Pleural / complications
  • Empyema, Pleural / diagnosis*
  • Empyema, Pleural / microbiology
  • Male
  • Pleural Effusion / complications
  • Pleural Effusion / diagnosis*
  • Rats
  • Rats, Wistar
  • Transforming Growth Factor beta1 / analysis*

Substances

  • Biomarkers
  • Transforming Growth Factor beta1